奎瑞通过表观遗传调节激活p16-INK4基因表达来抑制质瘤干细胞
Jianliang Li1, Jingchen Li1, Erkun Guo1
1The Second Hospital of Hebei Medical University, No.215 Heping West Road, Shijiazhuang, 050000, Hebei, China.
Anti-cancer agents in medicinal chemistry
|February 4, 2025
概括
Quercetin 是一种天然化合物,通过激活 p16-INK4 基因来抑制质瘤细胞的生长. 这通过表观遗传调节发生,为脑瘤提供了潜在的治疗途径.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 质母细胞瘤是一种具有有限治疗选择的侵袭性脑瘤.
- 瘤干细胞 (GSCs) 与瘤复发和对治疗的抵抗有关.
- 奎尔赛丁是一种具有潜在抗癌性能的黄类化合物.
研究的目的:
- 为了研究奎尔丁对质瘤干细胞的影响.
- 阐明瑞对GSCs作用的基因分子机制.
主要方法:
- 用奎思丁治疗质母细胞瘤和质母细胞瘤干细胞系.
- 评估细胞活力和细胞亡.
- 分析p16INK4a蛋白质和mRNA表达通过西方涂抹和qPCR.
- 染色体免疫沉以评估在p16-INK4位点的H3K27me3丰富.
主要成果:
- 奎尔赛丁抑制了U373MG细胞的活力和诱导的亡.
- Quercetin 在高度下抑制了一些 GSC 系列 (G3,G10,G15,G17) 的活力.
- 奎尔赛丁增加了p16INK4a的表达,并减少了H3K27me3在GSC中的p16-INK4位点.
结论:
- 奎尔在质瘤细胞上表现出抗增殖和促亡的作用.
- 奎尔塞丁通过表观遗传修饰 (减少H3K27me3) 激活p16INK4a基因表达.
- 素的表观遗传调节为脑瘤提供了潜在的治疗策略.
更多相关视频
09:26Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
16.6K
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
相关概念视频
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
